p57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions

Human Pathology

Volumn 39, Issue 1, 2008, Pages 63-72

  Hoffner, Lori ^a   Dunn, Jeanette ^b   Esposito, Nicole ^b   Macpherson, Trevor ^b   Surti, Urvashi ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Androgenetic; Complete hydatidiform mole; Hydropic abortus; p57KIP2 immunostaining; Placental mesenchymal dysplasia

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ADOLESCENT; ADULT; ARTICLE; CELL LINE; CHIMERA; CYTOGENETICS; DIPLOIDY; DYSPLASIA; FEMALE; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MOSAICISM; PHENOTYPE; PLACENTA; TETRAPLOIDY; TRIPLOIDY; CHEMISTRY; CHROMOSOME ABERRATION; EVALUATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENOME IMPRINTING; PREGNANCY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TROPHOBLAST;

CELL LINE; CHIMERA; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P57; FEMALE; GENOMIC IMPRINTING; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; PHENOTYPE; PREGNANCY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TROPHOBLASTS;

EID: 36749001048     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.05.010     Document Type: Article

References (22)

1. KIP2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest 78 (1998) 269-276
2. KIP2. Am J Surg Pathol 25 (2001) 1225-1230
3. Fisher R.A., Hodges M.D., Rees H.C., et al. The maternally transcribed gene p57(KIP2) (CDNK1C) is abnormally expressed in both androgenetic and biparental complete hydatidiform moles. Hum Mol Genet 26 (2002) 3267-3272
4. KIP2 expression in early hydatidiform moles. Hum Pathol 33 (2002) 1188-1192
5. KIP2 to assist molar classification. J Reprod Med 47 (2002) 342-346
6. KIP2 in hydatidiform mole and its clinical implication. J Huazhong Univ Sci Technolog Med Sci 22 (2002) 21-2, 157
7. KIP2 immunohistochemistry. Histopathology 43 (2003) 363-373
8. KIP2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology 43 (2003) 17-25
9. Thaker H.M., Berlin A., Tycko B., et al. Immunohistochemistry for the imprinted gene product IPL/PHLDA2 for facilitating the differential diagnosis of complete hydatidiform mole. J Reprod Med 49 (2004) 630-636
10. Fisher R.A., Nucci M.R., Thaker H.M., Weremowicz S., Genest D.R., and Castrillon D.H. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol 17 (2004) 1155-1160
11. Kihara M., Matsui H., Seki K., Nagai Y., Wake N., and Sekiya S. Genetic origin and imprinting in hydatidiform moles. Comparison between DNA polymorphism analysis and immunoreactivity of p57KIP2. J Reprod Med 50 (2005) 307-312
12. KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol 36 (2005) 180-186
13. Popiolek D.A., Yee H., Mittal K., et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol 37 (2006) 1426-1434
14. Matsouka S., Thompson J.S., Edwards M.C., et al. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Nat Acad Sci U S A 93 (1996) 3026-3030
15. Kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med 128 (2004) 897-900
16. Fisher R.A. Genetics. In: Hancock B.W. (Ed). Gestational trophoblastic disease (2003), Chapman and Hall Medical, London-New York 5-26
17. Szulman A.E., and Surti U. The syndromes of hydatidiform mole. Morphologic evolution of the complete and partial mole. Am J Obstet Gynecol 132 (1978) 120-127
18. Makrydimas G., Sebire N.J., Thornton S.E., Zagorianakou N., Lolis D., and Fisher R.A. Complete hydatidiform mole and normal live birth: a novel case of confined placental mosaicism: case report. Hum Reprod 17 (2002) 2459-2463
19. Surti U., Hill L.M., Dunn J., Prosen T., and Hoffner L. Twin pregnancy with a chimeric androgenetic and biparental placental in one twin displaying placental mesenchymal dysplasia phenotype. Prenat Diagn 25 (2005) 1048-1056
20. Kaiser-Rogers K.A., McFadden D.E., Livasy C.A., et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 43 (2006) 187-192
21. Robinson W.P., Lauzon J.L., Innes A.M., Lim K., Arsovska S., and McFadden D.E. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 27 (2007) 1114-1122
22. Surti U., Hoffner L., Kolthoff M., et al. Persistent gestational trophoblastic disease after an androgenetic/biparental fetal chimera: a case report and review. Int J Gynecol Pathol 25 (2006) 366-372